A study from Oxford University found that the number of people who get blood clots after being vaccinated with a coronavirus vaccine is about the same for those who get Pfizer PFE
and Modern MRNA,
vaccines as for the AstraZeneca AZN,
vaccine produced with the university’s help. According to the study, 4 out of 1 million people experience cerebral venous thrombosis after receiving the Pfizer or Moderna vaccine, compared to 5 out of 1 million people for the AstraZeneca vaccine. The risk of getting CVT is much higher for those who get COVID-19 – 39 out of a million patients – than for those who are vaccinated. The use of AstraZeneca vaccine has been discontinued or restricted in many countries due to blood clot disorders.
